Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q19598101> ?p ?o }
Showing triples 1 to 47 of
47
with 100 triples per page.
- Q19598101 subject Q10090201.
- Q19598101 subject Q8556404.
- Q19598101 subject Q8645495.
- Q19598101 subject Q8762123.
- Q19598101 subject Q9056368.
- Q19598101 abstract "Naltalimide (INN) (code name TRK-130, formerly TAK 363) is a novel, centrally-acting opioid drug which is under development by Takeda and Toray for the treatment of overactive bladder/urinary incontinence. It acts as a potent and selective partial agonist of the μ-opioid receptor (Ki = 0.268 nM, EC50 = 2.39 nM, Emax = 66.1%) over the δ-opioid (Ki = 121 nM, EC50 = 26.1 nM, Emax = 71.0%) and κ-opioid receptors (Ki = 8.97 nM, EC50 = 9.51 nM, Emax = 62.6%). Notably, naltalimide somehow appears to lack certain undesirable side effects such as constipation seen with other μ-opioid receptor agonists such as morphine. It enhances bladder storage via suppression of the afferent limb of the micturition reflex pathway.".
- Q19598101 atcPrefix "None".
- Q19598101 casNumber "160359-68-2".
- Q19598101 iupacName "2-[(5α,6β)-17-(Cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-yl]-1H-isoindole-1,3(2H)-dione".
- Q19598101 pubchem "16066809".
- Q19598101 thumbnail Naltalimide.svg?width=300.
- Q19598101 wikiPageWikiLink Q10090201.
- Q19598101 wikiPageWikiLink Q105726.
- Q19598101 wikiPageWikiLink Q14897645.
- Q19598101 wikiPageWikiLink Q14911924.
- Q19598101 wikiPageWikiLink Q168115.
- Q19598101 wikiPageWikiLink Q17145461.
- Q19598101 wikiPageWikiLink Q178436.
- Q19598101 wikiPageWikiLink Q18030283.
- Q19598101 wikiPageWikiLink Q281490.
- Q19598101 wikiPageWikiLink Q286136.
- Q19598101 wikiPageWikiLink Q3269441.
- Q19598101 wikiPageWikiLink Q427523.
- Q19598101 wikiPageWikiLink Q47273.
- Q19598101 wikiPageWikiLink Q770260.
- Q19598101 wikiPageWikiLink Q81225.
- Q19598101 wikiPageWikiLink Q824258.
- Q19598101 wikiPageWikiLink Q8386.
- Q19598101 wikiPageWikiLink Q8556404.
- Q19598101 wikiPageWikiLink Q8645495.
- Q19598101 wikiPageWikiLink Q874632.
- Q19598101 wikiPageWikiLink Q8762123.
- Q19598101 wikiPageWikiLink Q899133.
- Q19598101 wikiPageWikiLink Q9056368.
- Q19598101 wikiPageWikiLink Q9382.
- Q19598101 atcPrefix "None".
- Q19598101 casNumber "160359".
- Q19598101 iupacName "2".
- Q19598101 pubchem "16066809".
- Q19598101 type ChemicalSubstance.
- Q19598101 type Drug.
- Q19598101 type ChemicalObject.
- Q19598101 type Thing.
- Q19598101 type Q8386.
- Q19598101 comment "Naltalimide (INN) (code name TRK-130, formerly TAK 363) is a novel, centrally-acting opioid drug which is under development by Takeda and Toray for the treatment of overactive bladder/urinary incontinence. It acts as a potent and selective partial agonist of the μ-opioid receptor (Ki = 0.268 nM, EC50 = 2.39 nM, Emax = 66.1%) over the δ-opioid (Ki = 121 nM, EC50 = 26.1 nM, Emax = 71.0%) and κ-opioid receptors (Ki = 8.97 nM, EC50 = 9.51 nM, Emax = 62.6%).".
- Q19598101 label "Naltalimide".
- Q19598101 depiction Naltalimide.svg.